ATHE Alterity publishes latest quarterly earnings report outlining new advancement plans for its lead neurological drug candidate Microsoft Corporation MSFT Shares Decline 2 Following Amended NonExclusive OpenAI Partnership Announcement Is Rein Therapeutics RNTX stock testing important levels Q4 2025 Profit Disappoints